Souza Marcio's most recent trade in Praxis Precision Medicines Inc was a trade of 401 Common Stock done at an average price of $85.4 . Disclosure was reported to the exchange on Feb. 12, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.40 per share. | 12 Feb 2025 | 401 | 53,559 | - | 85.4 | 34,245 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 37,500 | 53,960 | - | 0 | Common Stock | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.52 per share. | 07 Jan 2025 | 434 | 16,460 | - | 77.5 | 33,644 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 185,000 | 185,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.37 per share. | 14 May 2024 | 1,718 | 16,894 | - | 12.4 | 21,248 | Common Stock |
Praxis Precision Medicines... | Souza Marcio | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.65 per share. | 12 Feb 2024 | 271 | 15,176 | - | 44.6 | 12,100 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.19 per share. | 07 Jan 2024 | 418 | 15,447 | - | 25.2 | 10,529 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 12 May 2023 | 11,687 | 237,986 | - | 0.9 | 10,331 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 23 Mar 2023 | 35,001 | 35,001 | - | 0.9 | 30,207 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 23 Mar 2023 | 35,000 | 226,299 | - | 0.9 | 30,160 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 213,975 | 213,975 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 14 Nov 2022 | 2,115 | 191,299 | - | 1.8 | 3,830 | Common Stock |
Aeglea BioTherapeutics Inc | Marcio Souza | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 25 Aug 2022 | 90,000 | 90,000 (0%) | 0% | 0.6 | 50,472 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 08 Jun 2022 | 27,000 | 189,184 | - | 1.8 | 49,888 | Common Stock |
Aeglea BioTherapeutics Inc | Marcio Souza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 43,000 | 43,000 | - | - | Director Stock Option (right to buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 8.80 per share. | 13 May 2022 | 1,392 | 162,184 | - | 8.8 | 12,247 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 259,000 | 259,000 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 74,000 | 160,792 | - | 0 | Common Stock | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.79 per share. | 18 Aug 2021 | 9,542 | 86,792 | - | 15.8 | 150,668 | Common Stock |
Aeglea BioTherapeutics Inc | Marcio Souza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 60,000 | 60,000 | - | - | Director Stock Option (right to buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 184,800 | 184,800 | - | - | Stock Option (Right to Buy) | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 52,800 | 77,250 | - | 0 | Common Stock | |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 26.08 per share. | 10 Nov 2020 | 3,846 | 24,450 | - | 26.1 | 100,304 | Common Stock |
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | 20 Oct 2020 | 44,092 | 0 | - | - | Series C -1 Preferred Stock | ||
Praxis Precision Medicines... | Marcio Souza | Director, Chief Executive Officer | 20 Oct 2020 | 20,604 | 20,604 | - | - | Common Stock |